Acute effects of acetaminophen on renal function and urinary excretion of some proteins and enzymes in patients with kidney disease

Renal Failure

Volumn 21, Issue 5, 1999, Pages 525-532

  Mitic Zlatkovic, Marina ^a   Stefanovic, Vladisav ^a,b  

^a Faculty of Medicine

^b Inst of Nephrology and Hemodialysis

Author keywords

Acetaminophen; Biomarkers; Kidney function; Urinary enzymes; Urinary proteins

Indexed keywords

BETA 2 MICROGLOBULIN; DIPEPTIDYL PEPTIDASE IV; GAMMA GLUTAMYLTRANSFERASE; MICROSOMAL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; PARACETAMOL; PROTEIN;

ADULT; AGED; ANALGESIA; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EXCRETION; DRUG MECHANISM; ENZYME METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; NEPHROTOXICITY; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0032819933     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229909045192     Document Type: Article

References (17)

1. Spüler O, Zollinger HU: Die chronisch-interstitielle Nephritis. Z Klin Med 151:1-50, 1953.
2. Pommer W, Bronder E, Greisser E, Buckalew VM, Blythe VM, Burgess WP: Regular analgesic intake and the risk of end-stage renal failure. Am J Nephrol 9:403-412, 1989.
3. Sandler DP, Smith JC, Weinberg CR, Helmert U, Jesdinsky HJ, Klimpel A, Borner K, Molzahn M: Analgesic use and chronic renal disease. N Engl J Med 320:1238-1243, 1989.
4. Perneger TV, Whelton PK, Klag MJ: Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflamatory drugs. N Engl J Med 331:1675-1679, 1994.
5. Blackely P, McDonald BR: Acute renal failure due to acetaminophen ingestion: a case report and review of the literature. J Am Soc Nephrol 6:48-53, 1995.
6. Pesce MA, Strande CS: A new micromethod for determination of protein in cerebrospinal fluid and urine. Clin Chem 19; 1265-1267, 1973.
7. Diener U, Knoll E, Langer B, Rautenstrauch N, Ratge D, Wisser N: Urinary excretion of N-acetyl-β-D glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cisplatinum. Clin Chim Acta 112:149-157, 1981.
8. Wolf GB, Scherberich JE, Fischer P, Schoeppe W: Isolation and characterization of dipeptidyl aminopeptidase IV from human kidney cortex. Clin Chim Acta 179:61-72, 1989.
9. Rosalki SB, Tarlow D: Optimized determination of gama-glutamyltransferase by reaction-rate analysis. Clin Chem 20:1121-1124, 1974.
10. Evrin PE, Peterson PA, Wide L, Berggard L: Radioimmunoassay of β2-microglobulin in human biological fluids. Scand J Clin Lab Invest 28:439-443, 1971.
11. Woo J, Floyd M, Cannon DC, Kaahan B: Radioimmunoassay for urinary albumin. Clin Chem 24:1464-1467, 1978.
12. Prescott LF: Paracetamol overdosage: Pharmacological considerations and clinical menagement. Drugs 25:290-314, 1983.
13. Mitchell JR, McMurtry RJ, Statham CM, Nelson SD: Molecular basis for several drug-induced nephropathies. Am J Med 62:518-526, 1997.
14. Newton JF, Pasino DA, Hook JB: Acetaminophen nephrotoxicity in the rat: Quantification of renal metabolic activation in vivo. Toxicol Appl Pharm 78:39-46, 1985.
15. Trumper L, Girardi G, Ellias MM: Acetaminophen nephrotoxicity in male Wistar rats. Arch Toxicol 66:107-111, 1992.
16. Casadevall G, Moreno JJ, Franch MA, Queralt J: N-acetyl-β-D-glucosaminidase (NAG) and alanine aminopeptidase (AAP) excretion after acute administration of acetaminophen, salsalate and aspirin in rats. Res Commun Chem Pathol Pharmacol 81:77-89, 1993.
17. Ronco PM, Flahault A: Drug-induced end stage renal disease. N Engl J Med 331:1711-1712, 1994.